John Lewicki
Vermogen: 31 932 $ op 31-05-2026
Vermogen: 31 932 $ op 31-05-2026
Dr. John A. Lewicki is a Chief Scientific Officer at Mereo BioPharma Group Plc.
Dr. Lewicki was previously employed as a President, Chief Executive Officer & Director by OncoMed Pharmaceuticals, Inc. and a Principal by Scios, Inc. He received his doctorate degree from the University of California San Diego.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-02-2026 | 464.130 ( 0,06% ) | 31 932 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Hoofd Techniek/Wetenschap/O&O | 01-07-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Algemeen Directeur | 23-04-2019 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau